nifedipine has been researched along with Graft vs Host Disease in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liesveld, J | 1 |
| Duerst, R | 1 |
| Rapoport, A | 1 |
| Constine, L | 1 |
| Abboud, C | 1 |
| Packman, C | 1 |
| Wedow, L | 1 |
| Zwetsch, L | 1 |
| McKenna, B | 1 |
| Linder, T | 1 |
| Silverman, W | 1 |
| Swift, S | 1 |
| Rowe, J | 1 |
| DiPersio, J | 1 |
1 other study available for nifedipine and Graft vs Host Disease
| Article | Year |
|---|---|
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of | 1999 |